
Sign up to save your podcasts
Or


In this episode, Anthony and Bernie are joined by Multiple Myeloma expert Dr. Manni Mohyuddin, to discuss the recent FDA approval updates of CAR-T in this disease state. We also discuss the hotly debated topic of MRD as a surrogate endpoint for accelerated approval in Myeloma.
 By Bernard Marini, Anthony Perissinotti, et al.
By Bernard Marini, Anthony Perissinotti, et al.4.5
2828 ratings
In this episode, Anthony and Bernie are joined by Multiple Myeloma expert Dr. Manni Mohyuddin, to discuss the recent FDA approval updates of CAR-T in this disease state. We also discuss the hotly debated topic of MRD as a surrogate endpoint for accelerated approval in Myeloma.

496 Listeners

27 Listeners

185 Listeners

8,672 Listeners

2 Listeners

756 Listeners

12 Listeners

53 Listeners

57 Listeners

136 Listeners

1 Listeners

49 Listeners

188 Listeners

43 Listeners

3 Listeners